Evaluation on the effectiveness and safety of COVID19 immunization in children with underlying disease
- Conditions
- Injury, poisoning and certain other consequences of external causes
- Registration Number
- KCT0007637
- Lead Sponsor
- Korea University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 330
Among outpatients 5-15 years old who have underlying diseases such as autoimmune disease, chronic kidney disease, or immunosuppressant taking autoimmune suppressants who visit Seoul National University Children's Hospital, patients who have received a COVID-19 vaccine.
- Children without underlying medical conditions
- Children who have never been vaccinated against COVID-19
- When the child or parent does not consent to participate in the study
- If the foreign parent is the guardian who has difficulty understanding the explanation and consent form in Korean
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse Drug Event
- Secondary Outcome Measures
Name Time Method COVID-19 infection after vaccination